Pharmacovigilance Expertise Vigilare International is a long-standing safety services provider with 45 years of combined leadership experience in pharmacovigilance, offering highly educated healthcare professionals and a rigorous Quality Management Plan to ensure data quality and compliance. This positions them as a reliable partner for biotech and pharma firms seeking robust post-market safety monitoring, signal management, and case processing.

Niche Focus The company specializes in pharmaceutical, biotechnology, and medical device product safety services, suggesting opportunities to upsell integrated safety solutions to mid-market and emerging growth clients looking for end-to-end pharmacovigilance and drug safety programs.

Small Firm Advantage With a lean team size of 11-50 employees and reported revenue under $1M, Vigilare presents a growth opportunity for larger CROs to partner on moonlighting or pilot programs, while also offering potential clients a nimble engagement model, rapid onboarding, and personalized service.

Strategic Leadership Angela Pitwood, Vice President, oversees all programs and brings extensive experience managing hundreds of thousands of events across multiple drugs, signaling a clear decision-maker contact and a proven governance framework that can be leveraged in sales conversations to address scale and quality concerns.

Acquisition Context Recent news indicates Vigilare was acquired in late 2017 by WCG Clinical, providing a selling point around a larger network, potential access to broader resources, and cross-sell opportunities with WCG Clinical’s pharmacovigilance and clinical research solutions for clients seeking integrated services.